News

Filter

Novo Nordisk expands HEPtune drug delivery deal with Caisson Biotech

Novo Nordisk expands HEPtune drug delivery deal with Caisson Biotech

11-03-2014

Caisson Biotech, a wholly-owned subsidiary of Heparinex and owner of a patented heparosan-based drug…

BiotechnologyCaisson BiotechDiabetesInflammatory diseasesLicensingMetabolicsNovo Nordisk

In Japan, Mitsubishi Tanabe files for canagliflozin approval; Eisai/AbbVie's Humira gets new indication

28-05-2013

Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) said yesterday (May 27) that it has submitted…

AbbVieAsia-PacificBiotechnologycanagliflozinDiabetesEisaiHumiraInflammatory diseasesInvokanaMitsubishi TanabePharmaceuticalRegulation

COMPANY SPOTLIGHT

Menarini

Back to top